Skip to content
DraconiticResearch
Search Sources API
197,768 studies31 sourcesUpdated 16 min ago
Peer-reviewedCC BY 4.0PLOS One

Azithromycin and its non-antibacterial derivative EP317 attenuate select aspects of ventilator-induced lung injury in rats

  • Sigurbergur Karason1
  • Arni Asbjarnarson2
  • Saevar Ingthorsson3
  • Kolbrun Bjork Jonasdottir4
  • Jennifer Kricker5
  • Thorarinn Gudjonsson
  • Jon Petur Joelsson
5 affiliations
  1. 1Department of Anaesthesia and Intensive Care, Landspitali-University Hospital, Reykjavik, Iceland
  2. 2Stem Cell Research Unit, BioMedical Centre, School of Health Sciences, University of Iceland, Reykjavik, Iceland
  3. 3Faculty of Nursing and Midwifery, University of Iceland, Reykjavik, Iceland
  4. 4EpiEndo Pharmaceuticals, Reykjavik, Iceland
  5. 5Department of Laboratory Hematology, Landspitali-University Hospital, Reykjavik, Iceland
Open at sourcePDFDOICite

Abstract

Ventilator-induced lung injury (VILI) is a significant complication of mechanical ventilation, contributing to morbidity and mortality in critically ill patients. Excessive mechanical stress triggers an inflammatory cascade, leading to lung damage, pulmonary oedema, and systemic complications. While macrolide antibiotics such as azithromycin (AZM) have demonstrated anti-inflammatory and epithelial barrier strengthening effects, their use is limited by concerns regarding antibiotic resistance. EP317, an azithromycin-derived compound with negligible antibacterial activity, was designed to retain the immunomodulatory and epithelial barrier enhancing effects of AZM while mitigating the risk of bacterial resistance. This study investigated the effects of AZM and EP317 in a rat model of VILI. Forty-eight rats were divided into six groups (N = 8 per group), receiving either placebo, AZM, or EP317 (5 mg/kg daily for seven days), with half of the animals subjected to mechanical ventilation with peak airway pressure at 35 cmH2O. Both compounds attenuated ventilation-induced pulmonary oedema, reflected in a smaller increase in lung wet/dry ratio, whereas ventilation-induced increases in total protein in bronchoalveolar lavage fluid (BALF) were not significantly reduced by either treatment. Cytokine profiling in plasma (L-Selectin, PAI-1, RANTES, MCP-3, IL-6, SCF, IL-17a, RAGE, MIP-3α, IL-13, G-CSF, IL-10, M-CSF, IFN-γ, GRO-KC and MMP9) revealed that both treatments attenuated inflammatory responses, while cytokine levels in BALF in ventilated animals were either unchanged or increased. Survival rates were improved in the treatment groups. Histological analysis indicated increased oedema in ventilated animals, likely due to the high-pressure ventilation, while drug-treated groups exhibited reduced oedema. Global gene expression profiling by RNA sequencing revealed robust upregulation of inflammatory and stress-response pathways in ventilated animals, with partial attenuation following AZM or EP317 pre-treatment. These findings suggest that EP317 and AZM offer protective effects against VILI. EP317 presents a promising alternative to conventional macrolide therapy by circumventing antibiotic resistance concerns.

Related

  1. The impact of prophylactic azithromycin on the developing preterm gut microbiome and resistome.
    Sinead Ahearn-Ford, Ali Aboklaish, Gregory R Young +7
    Gut microbesPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  2. Ginseng derived extracellular vesicles attenuate adipocyte hypertrophy and modulate gut microbiota and cholecystokinin responsiveness in high fat diet fed mice
    Eunji Jeong, Seoyeon Chae, Hyunwoo Chai +2
    Scientific ReportsPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationCrossref
  3. Casein Hydrolysate Peptides Attenuate Immunosenescence and Inflammaging in a D-Galactose-Induced Mouse Model of Aging.
    Mengni Cui, Zheng Xu, Jianbo Cheng +3
    BiologyPeer-reviewedCC BYFull textMolecular biology & gene regulationEurope PMC
  4. Phenylthioether chalcone derivatives attenuate acute lung injury via suppression of p38 MAPK (MAPK14)-mediated inflammatory signaling
    Qin-Li Yi, Xue-Jian Zhou, Zhao-Feng Wu +4
    Results in ChemistryPeer-reviewedCC BYFull textMolecular biology & gene regulationDOAJ
  5. Inhibiting MD2 activates AMPK-dependent PPARγ/NOX4 signaling to attenuate mitochondrial oxidative stress and relieve pulmonary hypertension
    Jun Chen, Mengyu Chai, Yichen Liu +10
    Redox BiologyPeer-reviewedCC BY-NC-ND 4.0Full textMolecular biology & gene regulationGeneral biologyDOAJPMC

Cite

BibTeXRIS
BibTeX
@article{karason2026azithromycin,
  title = {{Azithromycin and its non-antibacterial derivative EP317 attenuate select aspects of ventilator-induced lung injury in rats}},
  author = {Sigurbergur Karason and Arni Asbjarnarson and Saevar Ingthorsson and Kolbrun Bjork Jonasdottir and Jennifer Kricker and Thorarinn Gudjonsson and Jon Petur Joelsson},
  journal = {PLOS One},
  year = {2026},
  month = sep,
  doi = {10.1371/journal.pone.0358745},
  url = {https://doi.org/10.1371/journal.pone.0358745},
  note = {CC BY 4.0},
}
RIS
TY  - JOUR
TI  - Azithromycin and its non-antibacterial derivative EP317 attenuate select aspects of ventilator-induced lung injury in rats
AU  - Sigurbergur Karason
AU  - Arni Asbjarnarson
AU  - Saevar Ingthorsson
AU  - Kolbrun Bjork Jonasdottir
AU  - Jennifer Kricker
AU  - Thorarinn Gudjonsson
AU  - Jon Petur Joelsson
PY  - 2026
DA  - 2026/09/24
JO  - PLOS One
DO  - 10.1371/journal.pone.0358745
UR  - https://doi.org/10.1371/journal.pone.0358745
AB  - Ventilator-induced lung injury (VILI) is a significant complication of mechanical ventilation, contributing to morbidity and mortality in critically ill patients. Excessive mechanical stress triggers an inflammatory cascade, leading to lung damage, pulmonary oedema, and systemic complications. While macrolide antibiotics such as azithromycin (AZM) have demonstrated anti-inflammatory and epithelial barrier strengthening effects, their use is limited by concerns regarding antibiotic resistance. EP317, an azithromycin-derived compound with negligible antibacterial activity, was designed to retain the immunomodulatory and epithelial barrier enhancing effects of AZM while mitigating the risk of bacterial resistance. This study investigated the effects of AZM and EP317 in a rat model of VILI. Forty-eight rats were divided into six groups (N = 8 per group), receiving either placebo, AZM, or EP317 (5 mg/kg daily for seven days), with half of the animals subjected to mechanical ventilation with peak airway pressure at 35 cmH2O. Both compounds attenuated ventilation-induced pulmonary oedema, reflected in a smaller increase in lung wet/dry ratio, whereas ventilation-induced increases in total protein in bronchoalveolar lavage fluid (BALF) were not significantly reduced by either treatment. Cytokine profiling in plasma (L-Selectin, PAI-1, RANTES, MCP-3, IL-6, SCF, IL-17a, RAGE, MIP-3α, IL-13, G-CSF, IL-10, M-CSF, IFN-γ, GRO-KC and MMP9) revealed that both treatments attenuated inflammatory responses, while cytokine levels in BALF in ventilated animals were either unchanged or increased. Survival rates were improved in the treatment groups. Histological analysis indicated increased oedema in ventilated animals, likely due to the high-pressure ventilation, while drug-treated groups exhibited reduced oedema. Global gene expression profiling by RNA sequencing revealed robust upregulation of inflammatory and stress-response pathways in ventilated animals, with partial attenuation following AZM or EP317 pre-treatment. These findings suggest that EP317 and AZM offer protective effects against VILI. EP317 presents a promising alternative to conventional macrolide therapy by circumventing antibiotic resistance concerns.
SN  - 1932-6203
ER  -